Stay updated on Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial page.

Latest updates to the Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check8 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier was updated from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, effectively restricting access to the study record and related navigation.SummaryDifference19%

- Check50 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a newer version of the study record.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded official study documents (Informed Consent Form and Study Protocol with Statistical Analysis Plan), sponsor and collaborator details, IPD plan status, and drug/MeSH metadata for the NCT03631641 record. Removed an error-page snippet that previously appeared when the page failed to load.SummaryDifference54%

- Check71 days agoChange DetectedRevision: v3.6.5 appears in the page footer, replacing the previous Revision: v3.6.4. This reflects a new site build and does not affect the study content or data shown on the page.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial page.